These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36495688)

  • 1. Inside and outside of virus-like particles HBc and HBc/4M2e: A comprehensive study of the structure.
    Egorov VV; Shvetsov AV; Pichkur EB; Shaldzhyan AA; Zabrodskaya YA; Vinogradova DS; Nekrasov PA; Gorshkov AN; Garmay YP; Kovaleva AA; Stepanova LA; Tsybalova LM; Shtam TA; Myasnikov AG; Konevega AL
    Biophys Chem; 2023 Feb; 293():106943. PubMed ID: 36495688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
    Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
    Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
    Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
    Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CONSTRUCTION OF MOSAIC HBC PARTICLES PRESENTING CONSERVATIVE FRAGMENTS OF M2 PROTEIN AND HEMAGGLUTININ OF INFLUENZA A VIRUS.
    Blokhina EA; Ravin NV
    Vopr Virusol; 2018 Jun; 63(3):130-135. PubMed ID: 36494939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis.
    Aston-Deaville S; Carlsson E; Saleem M; Thistlethwaite A; Chan H; Maharjan S; Facchetti A; Feavers IM; Alistair Siebert C; Collins RF; Roseman A; Derrick JP
    Vaccine; 2020 Apr; 38(16):3201-3209. PubMed ID: 32178907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3.5Å cryoEM structure of hepatitis B virus core assembled from full-length core protein.
    Yu X; Jin L; Jih J; Shih C; Zhou ZH
    PLoS One; 2013; 8(9):e69729. PubMed ID: 24039702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and characterization of HBc virus like particles with site-directed coupling function].
    Liu D; Li B; Bi C; Qiao H; Wu X
    Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1440-1449. PubMed ID: 32748602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folding and assembly of hepatitis B virus core protein: a new model proposal.
    Bringas R
    J Struct Biol; 1997 Apr; 118(3):189-96. PubMed ID: 9169229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
    De Filette M; Martens W; Smet A; Schotsaert M; Birkett A; Londoño-Arcila P; Fiers W; Saelens X
    Vaccine; 2008 Dec; 26(51):6503-7. PubMed ID: 18835315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles.
    Blokhina EA; Kuprianov VV; Stepanova LA; Tsybalova LM; Kiselev OI; Ravin NV; Skryabin KG
    Virology; 2013 Jan; 435(2):293-300. PubMed ID: 23062739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential formation of disulfide linkages in the core antigen of extracellular and intracellular hepatitis B virus core particles.
    Jeng KS; Hu CP; Chang CM
    J Virol; 1991 Jul; 65(7):3924-7. PubMed ID: 2041102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
    Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
    Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV core particles as a carrier for B cell/T cell epitopes.
    Pumpens P; Grens E
    Intervirology; 2001; 44(2-3):98-114. PubMed ID: 11509871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.
    Kazaks A; Lachmann S; Koletzki D; Petrovskis I; Dislers A; Ose V; Skrastina D; Gelderblom HR; Lundkvist A; Meisel H; Borisova G; Krüger DH; Pumpens P; Ulrich R
    Intervirology; 2002; 45(4-6):340-9. PubMed ID: 12602354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein.
    Ravin NV; Kotlyarov RY; Mardanova ES; Kuprianov VV; Migunov AI; Stepanova LA; Tsybalova LM; Kiselev OI; Skryabin KG
    Biochemistry (Mosc); 2012 Jan; 77(1):33-40. PubMed ID: 22339631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris.
    Freivalds J; Dislers A; Ose V; Pumpens P; Tars K; Kazaks A
    Protein Expr Purif; 2011 Feb; 75(2):218-24. PubMed ID: 20854910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proline-138 is essential for the assembly of hepatitis B virus core protein.
    Metzger K; Bringas R
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():587-90. PubMed ID: 9519838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.
    Yin Y; Zhang S; Cai C; Zhang J; Dong D; Guo Q; Fu L; Xu J; Chen W
    Immunobiology; 2014 Feb; 219(2):97-103. PubMed ID: 24054942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal influenza A vaccine: optimization of M2-based constructs.
    De Filette M; Min Jou W; Birkett A; Lyons K; Schultz B; Tonkyro A; Resch S; Fiers W
    Virology; 2005 Jun; 337(1):149-61. PubMed ID: 15914228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biomimetic VLP influenza vaccine with interior NP/exterior M2e antigens constructed through a temperature shift-based encapsulation strategy.
    Wei J; Li Z; Yang Y; Ma X; An W; Ma G; Su Z; Zhang S
    Vaccine; 2020 Aug; 38(38):5987-5996. PubMed ID: 32713681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.